Integrated analysis of programmed cell death ligand 1 expression reveals increased levels in high-grade glioma.
Dorothee HölzlGeorg HutarewBarbara ZellingerHans U SchlickerChristoph SchwartzPeter A WinklerKarl SotlarTheo F J KrausPublished in: Journal of cancer research and clinical oncology (2021)
In summary, we found that PD-L1 is highly expressed in a subfraction of glioma, indicating PD-L1 as a potential new marker in glioma assessment opening up novel therapeutic approaches.